Antiviral, vaccine makers step up to address 'high demand' US flu season
This article was originally published in Scrip
Executive Summary
The heads of the Centers for Disease Control and Prevention (CDC) and the FDA on 18 January confirmed what many in the US already know: Americans are being pounded by the flu – especially the elderly – and vaccine and antivirals in some cases are increasingly difficult to find.